Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.
- DOI
- 10.1016/j.bbi.2024.09.005
- Published
- 2025 Jan
- Container
- Brain, behavior, and immunity
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbi.2024.09.005,
title = {Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.},
author = {Leboyer M and Foiselle M and Tchitchek N and Tamouza R and Lorenzon R and Richard JR and Arrouasse R and Le Corvoisier P and Le Dudal K and Vicaut E and Ellul P and Rosenzwajg M and Klatzmann D},
year = {2025},
journal = {Brain, behavior, and immunity},
doi = {10.1016/j.bbi.2024.09.005},
url = {https://doi.org/10.1016/j.bbi.2024.09.005}
}RIS
TY - JOUR TI - Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial. AU - Leboyer M AU - Foiselle M AU - Tchitchek N AU - Tamouza R AU - Lorenzon R AU - Richard JR AU - Arrouasse R AU - Le Corvoisier P AU - Le Dudal K AU - Vicaut E AU - Ellul P AU - Rosenzwajg M AU - Klatzmann D PY - 2025 JO - Brain, behavior, and immunity DO - 10.1016/j.bbi.2024.09.005 UR - https://doi.org/10.1016/j.bbi.2024.09.005 ER -
APA
M, L., M, F., N, T., R, T., R, L., JR, R., R, A., P, L. C., K, L. D., E, V., P, E., M, R., & D, K. (2025). Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.. Brain, behavior, and immunity. https://doi.org/10.1016/j.bbi.2024.09.005
Source records
- pubmed · retrieved 2026-09-26T20:34:58.916Z
- europe-pmc · retrieved 2026-09-26T20:34:58.932Z
- hal · retrieved 2026-09-26T20:34:58.950Z